We are live on ! Find out more
HLA

Hamilton Lane Advisors Portfolio holdings

AUM $149M
1-Year Est. Return 14.17%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
-14.17%
3 Year Est. Return
+186.76%
5 Year Est. Return
+98.42%
10 Year Est. Return
+778.69%
AUM
$277M
AUM Growth
+$3.34M
Cap. Flow
+$10.1M
Cap. Flow %
3.64%
Top 10 Hldgs %
77.66%
Holding
77
New
11
Increased
12
Reduced
7
Closed
9

Top Buys

Rank Stock Value
1
GRNT icon
Granite Ridge Resources
GRNT
+$15.5M
2
NU icon
Nu Holdings
NU
+$10.3M
3
SNOW icon
Snowflake
SNOW
+$2.56M
4
CFLT
Confluent
CFLT
+$2.3M
5
GTLB icon
GitLab
GTLB
+$2.16M

Top Sells

Rank Stock Value
1
QS icon
QuantumScape Corp
QS
+$12.7M
2
AMAL icon
Amalgamated Financial
AMAL
+$8.88M
3
RELY icon
Remitly
RELY
+$3.07M
4
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$2.83M
5
ORGO icon
Organogenesis Holdings
ORGO
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 45.07%
2 Financials 32.63%
3 Healthcare 7.88%
4 Energy 5.6%
5 Consumer Discretionary 3.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SEMR
51
DELISTED
Semrush
SEMR
$397K 0.14%
48,828
– –
GH icon
52
Guardant Health
GH
$21.7B
$290K 0.1%
10,660
– –
NTRA icon
53
Natera
NTRA
$37.9B
$287K 0.1%
7,145
– –
NEWR
54
DELISTED
New Relic, Inc.
NEWR
$250K 0.09%
4,424
– –
LUNG icon
55
Pulmonx
LUNG
$69.7M
$246K 0.09%
29,150
– –
CMRC
56
Commerce.com Inc Series 1
CMRC
$256M
$237K 0.09%
27,100
– –
ASAN icon
57
Asana
ASAN
$1.89B
$208K 0.08%
15,129
– –
TVRD
58
Tvardi Therapeutics
TVRD
$19.1M
$173K 0.06%
448
– –
XPEV icon
59
XPeng
XPEV
$12.3B
$168K 0.06%
16,903
-43,401
-72% -$391K
SLGC
60
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$136K 0.05%
+54,255
New +$151K
ALEC icon
61
Alector
ALEC
$172M
$133K 0.05%
+14,402
New +$126K
HUMA icon
62
Humacyte
HUMA
$177M
$111K 0.04%
52,693
– –
DTIL icon
63
Precision BioSciences
DTIL
$180M
$94K 0.03%
2,637
– –
CLSD
64
DELISTED
Clearside Biomedical
CLSD
$73K 0.03%
+4,357
New +$78.5K
MTTR
65
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$71K 0.03%
25,461
-50,000
-66% -$160K
AEVA
66
Aeva Technologies
AEVA
$1.19B
$60K 0.02%
8,817
-17,900
-67% -$157K
VIRX
67
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$52K 0.02%
35,791
– –
PHAS
68
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$1K ﹤0.01%
+34,208
New +$5.61K
AMAL icon
69
Amalgamated Financial
AMAL
$1.47B
– –
-393,696
Closed -$8.88M
COIN icon
70
Coinbase
COIN
$37.1B
– –
-5,833
Closed -$376K
EVLV icon
71
Evolv Technologies
EVLV
$991M
– –
-29,074
Closed -$62K
IKT icon
72
Inhibikase Therapeutics
IKT
$341M
– –
-27,606
Closed -$151K
ORGO icon
73
Organogenesis Holdings
ORGO
$305M
– –
-445,985
Closed -$1.45M
QS icon
74
QuantumScape Corp
QS
$3.16B
– –
-1,509,667
Closed -$12.7M
RELY icon
75
Remitly
RELY
$4.76B
– –
-275,898
Closed -$3.07M
1 2
3
4

Similar funds

FFS
Flavin Financial Services Melbourne, Florida $149M AUM 14.79% 1-Year Est. Return
KCM
KM Capital Management Austin, Texas $149M AUM 18.7% 1-Year Est. Return
GCA
Gallagher Capital Advisors Argyle, Texas $148M AUM 20.92% 1-Year Est. Return
DAC
Dutch Asset Corp Selkirk, New York $149M AUM
RCM
Rockbridge Capital Management Alexandria, Virginia $149M AUM 1.06% 1-Year Est. Return
AWA
Authentikos Wealth Advisory Morgan Hill, California $148M AUM 9.86% 1-Year Est. Return
JWM
Jacksonville Wealth Management Jacksonville, Florida $148M AUM 23.77% 1-Year Est. Return
AWF
Alpha Wealth Funds Park City, Utah $149M AUM 10.03% 1-Year Est. Return

Hamilton Lane Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, Hamilton Lane Advisors held 77 positions worth $277M, up 1.2% from $273M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Hamilton Lane Advisors deployed $10.1M of net new capital in Q4 2022, opening 11 new positions and adding to 12 existing holdings. Its largest new stake was Granite Ridge Resources: 1,717,445 shares worth $15.5M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 44% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Karuna Therapeutics, Inc. Common Stock, an estimated $2.83M trimmed.

  • Hamilton Lane Advisors's largest Q4 2022 buy was Granite Ridge Resources: 1,717,445 shares worth $15.5M.
  • Hamilton Lane Advisors added most to Nu Holdings in Q4 2022, an estimated $10.3M increase.
  • Hamilton Lane Advisors's biggest Q4 2022 reduction was Karuna Therapeutics, Inc. Common Stock, cutting an estimated $2.83M.
  • Hamilton Lane Advisors fully exited QuantumScape Corp in Q4 2022, selling an estimated $12.7M.
  • Hamilton Lane Advisors's ten largest holdings make up 78% of its $277M portfolio in Q4 2022.
  • Hamilton Lane Advisors opened 11 new positions and closed 9 in Q4 2022.
  • Hamilton Lane Advisors's portfolio value rose 1.2% quarter-over-quarter to $277M.

Based on Hamilton Lane Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.